Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination

Adams, LE; Leist, SR; Dinnon, KH; West, A; Gully, KL; Anderson, EJ; Loome, JF; Madden, EA; Powers, JM; Schäfer, A; Sarkar, S; Castillo, IN; Maron, JS; McNamara, RP; Bertera, HL; Zweigert, MR; Higgins, JS; Hampton, BK; Premkumar, L; Alter, G; Montgomery, SA; Baxter, VK; Heise, MT; Baric, RS

Heise, MT; Baric, RS (通讯作者),Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.;Baric, RS (通讯作者),Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.;Heise, MT (通讯作者),Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.;Heise, MT; Baric, RS (通讯作者),Univ N Carolina, Rapidly Emerging Antiviral Drug Discovery Initiat, Chapel Hill, NC 27515 USA.

CELL REPORTS, 2023; 42 (4):

Abstract

Group 2B b-coronaviruses (sarbecoviruses) have caused regional and global epidemics in modern history. Here, we evaluate the mechanisms of cross-sarbe......

Full Text Link